IKT Stockholders Equity

Inhibikase Therapeutics Inc · Stockholders Equity

IKT logo

IKT Stockholders Equity

Latest reported$172.90M
IKT FY Shareholders Equity (-$1.35M → $172.90M)
High-resolution chart · PNG

IKT stockholders equity history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Stockholders Equity — Annual fiscal periods (USD)
Period endingStockholders Equity (USD)
172,903,679
94,866,280
10,977,922
21,035,401
38,415,549
9,784,356
-4,490,016
-777,965
-1,441,008
-1,351,710
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.